| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Veritas Health is a Deerfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Del Pilar Medical and Urgent Care Center is a Mishawaka, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ashley Ridge Imaging is a Shreveport, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NDSC`s solutions are widely adopted and in use across the entire healthcare provider market in all 50 states and Europe. Organizations ranging from large, multi-state, integrated delivery networks to standalone ambulatory care settings, caregivers trust NDSC CareSelect™ platform to manage and track the actionable delivery of thousands of evidence-based guidelines.